Vanda Pharmaceuticals (VNDA) EPS (Basic) (2010 - 2026)
Vanda Pharmaceuticals (VNDA) posted EPS (Basic) of -$0.82 for Q1 2026, up 65.94% sequentially from -$2.4 in Q4 2025, and down 61.94% YoY from -$2.14 in Q1 2025.
Vanda Pharmaceuticals (VNDA) EPS (Basic) (2010 - 2026) Analysis & Trends
Vanda Pharmaceuticals has reported EPS (Basic) for 17 years, with the latest figure at -$0.82 in Q1 2026.
- Quarterly EPS (Basic) fell 61.94% year-over-year to -$0.82 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.03 (down 432.95% YoY) and the FY2025 annual result came in at -$3.74, down 1051.07% from the prior year.
- EPS (Basic) rose to -$0.82 in Q1 2026 per VNDA's latest filing, from -$2.4 in the prior quarter.
- Over five years, EPS (Basic) peaked at $0.12 in Q4 2022 and troughed at -$2.4 in Q4 2025.
- A 5-year average of -$0.28 and a median of -$0.08 in 2024 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2023 and 2024: EPS (Basic) soared 149.14% in 2023, then slumped 3950.99% in 2024.
- Over 5 years, EPS (Basic) stood at $0.12 in 2022, then slumped by 134.29% to -$0.04 in 2023, then slumped by 101.24% to -$0.08 in 2024, then plunged by 2757.17% to -$2.4 in 2025, then surged by 65.94% to -$0.82 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.82, -$2.4, and -$0.38 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Vanda Pharmaceuticals | 315.57 Mn | 145.54 Mn | 46.97 Mn | -1.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.04 |
| Mar 31, 2026 | -0.82 |
| Dec 31, 2025 | -2.40 |
| Sep 30, 2025 | -0.38 |
| Jun 30, 2025 | -0.46 |
| Mar 31, 2025 | -0.50 |
| Dec 31, 2024 | -0.08 |
| Sep 30, 2024 | -0.09 |
| Jun 30, 2024 | -0.08 |
| Mar 31, 2024 | -0.07 |
| Dec 31, 2023 | -0.04 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.03 |
| Mar 31, 2023 | 0.06 |
| Dec 31, 2022 | 0.12 |
| Sep 30, 2022 | 0.06 |
| Jun 30, 2022 | 0.05 |
| Mar 31, 2022 | -0.12 |
| Dec 31, 2021 | 0.13 |
| Sep 30, 2021 | 0.14 |